Physician profile
James Chang
NPI 1447269626
$2,355.30
in general payments reported to CMS, 2019-2025
10 companies · $63.43 in 2025
The $63.43 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $570 · 2020: $1,140 · 2021: $317 · 2023: $19.71 · 2024: $245 · 2025: $63.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $327.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $746.01 | 2019-2025 | Arcphix System, Nanophix Implant, Innate Implant |
| Musculoskeletal Transplant Foundation INC. | $418.06 | 2020 | |
| Intuitive Surgical, INC. | $300.00 | 2020 | |
| Axogen | $231.22 | 2019-2021 | |
| Alafair Biosciences, INC. | $140.82 | 2023-2024 | Versawrap |
| Stryker Corporation | $138.32 | 2019-2021 | |
| Bioventus LLC | $122.30 | 2019 | |
| Integra Lifesciences Corporation | $119.52 | 2020 | |
| Trimed, INC. | $94.05 | 2021 | |
| Ethicon US, LLC | $45.00 | 2024 | Ethicon, Echelon Flex, Echelon Circular |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.